Royal National Throat Nose & Ear Hospital, London, U.K.
Rhinosinusitis response to therapy is objectively assessed with nasal nitric oxide
Published in Telemedicine Law Weekly, July 8th, 2006
According to a study from England, "The assessment of the response of chronic rhinosinusitis (CRS) to therapy is difficult. Computerized tomographic (CT) scans cannot be repeatedly used so measures such as symptom scores, endoscopic findings, and parallel measures such as saccharin clearance time are employed instead. Our objective was to study the effect of CRS therapy on nasal nitric oxide and to see whether nasal nitric oxide level changes correlate with other assessments."
S.M. Ragab and colleagues, Royal National...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly
More Articles from Telemedicine Law Weekly
- Bionovo
Bionovo highlights new assay data on menopausal drug - Centers for Disease Control and Prevention, U.S.
Automated solid-phase extraction method for measuring PAH metabolites developed - National Taiwan University, Taiwan
Recent findings in rectal cancer described by researchers from Taiwan and France - pSivida Limited
Aion Diagnostics reports BioSilicon breakthrough - West Tokyo Metropolitan Police Hospital, Tokyo, Japan
Ankle posterior malleolar fracture pathologic anatomy is studied - Accuray Incorporated
CyberKnife System enables patients to receive systemic chemotherapy sooner - More from this issue of Telemedicine Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
